Hepatitis B Virus (HBV) Therapeutics – Current and Future Players

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2995

GlobalData has released its pharma report, “Hepatitis B Virus (HBV) Therapeutics – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market. The report provides insight into the competitive HBV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.

Scope

Investigation of current and future market competition for HBV

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of HBV sector through market impact analysis, future market scenario and company analysis

Reasons to Buy

Gain a high level view of the trends shaping and driving HBV market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What’s the next big thing in the global HBV market landscape? Identify, understand and capitalize

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1Catalyst

2.2Related Reports

2.3Upcoming Related Reports

3Market Outlook

3.1Global Markets

3.1.1Forecast

3.1.2Drivers and Barriers – Global Issues

4Current and Future Players

4.1Overview

4.2Trends in Corporate Strategy

4.3Company Profiles

4.3.1Gilead

4.3.2Bristol-Myers Squibb

4.3.3Roche

4.3.4Merck

4.3.5GSK

4.3.6Novartis

4.3.7Arrowhead Research

4.3.8GlobeImmune

5Appendix

5.1Bibliography

5.2Abbreviations

5.3Methodology

5.4Forecasting Methodology

5.4.1Total Prevalent Cases of Chronic Hepatitis B

5.4.2Diagnosed Chronic Hepatitis B Patients

5.4.3Percent Drug-Treated Chronic Hepatitis B Patients

5.4.4Drugs Included in Each Therapeutic Class

5.4.5Launch and Patent Expiry Dates

5.4.6General Pricing Assumptions

5.4.7Individual Drug Assumptions

5.4.8Generic Erosion

5.4.9Pricing of Pipeline Agents

5.5Primary Research – KOLs Interviewed for this Report

5.6Primary Research – Prescriber Survey

5.7About the Authors

5.7.1Analyst

5.7.2Therapy Area Director

5.7.3Epidemiologists

5.7.4Global Director of Therapy Analysis and Epidemiology

5.7.5Global Head of Healthcare

5.8About GlobalData

5.9Disclaimer

Table

Table 1: Global Sales Forecasts ($m) for Chronic Hepatitis B Therapeutics, 2014–2024

Table 2: Chronic Hepatitis B Therapeutics Market – Drivers and Barriers, 2014–2024

Table 3: Key Companies in the Chronic Hepatitis B Therapeutics Market, 8MM, 2015

Table 4: Gilead’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 5: BMS’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 6: Roche’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 7: Merck’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 8: GSK’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 9: Novartis’ Chronic Hepatitis B Portfolio Assessment, 2015

Table 10: Arrowhead’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 11: GlobeImmune’s Chronic Hepatitis B Portfolio Assessment, 2015

Table 12: Key Historical and Projected Launch Dates

Table 13: Key Historical and Projected Patent Expiry Dates

Table 14: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country

Figures

Figure 1: Sales for Chronic Hepatitis B Therapeutics by Country, 2014–2024

Figure 2: Sales for Chronic Hepatitis B Therapeutics by Therapy Class, 2014–2024

Figure 3: Company Portfolio Gap Analysis in the Chronic Hepatitis B Therapeutic Market, 2014–2024

Frequently asked questions

Hepatitis B Virus (HBV) Therapeutics – Current and Future Players thematic reports
Currency USD
$2,995

Can be used by individual purchaser only

$8,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hepatitis B Virus (HBV) Therapeutics – Current and Future Players in real time.

  • Access a live Hepatitis B Virus (HBV) Therapeutics – Current and Future Players dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.